Scientific paper - Review paper
Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile
Basic & Clinical Pharmacology & Toxicology, 123 (2018), 4; 509-518. https://doi.org/10.1111/bcpt.13035


Cite this document

Vrkić Kirhmajer, M., Macolić Šarinić, V., Šimičević, L., Ladić, I., Putarek, K., Banfić, Lj. & Božina, N. (2018). Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile. Basic & Clinical Pharmacology & Toxicology, 123. (4), 509-518. doi: 10.1111/bcpt.13035

Vrkić Kirhmajer, Majda, et al. "Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile." Basic & Clinical Pharmacology & Toxicology, vol. 123, no. 4, 2018, pp. 509-518. https://doi.org/10.1111/bcpt.13035

Vrkić Kirhmajer, Majda, Viola Macolić Šarinić, Livija Šimičević, Iva Ladić, Krešimir Putarek, Ljiljana Banfić and Nada Božina. "Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile." Basic & Clinical Pharmacology & Toxicology 123, no. 4 (2018): 509-518. https://doi.org/10.1111/bcpt.13035

Vrkić Kirhmajer, M., et al. (2018) 'Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile', Basic & Clinical Pharmacology & Toxicology, 123(4), pp. 509-518. doi: 10.1111/bcpt.13035

Vrkić Kirhmajer M, Macolić Šarinić V, Šimičević L, Ladić I, Putarek K, Banfić Lj, and sur.. Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile. Basic & Clinical Pharmacology & Toxicology [Internet]. 2018 [cited 2024 June 18];123(4):509-518. doi: 10.1111/bcpt.13035

M. Vrkić Kirhmajer, et al., "Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile", Basic & Clinical Pharmacology & Toxicology, vol. 123, no. 4, pp. 509-518, 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:203793. [Accessed: 18 June 2024]